Global Electric Hand Dryer
At cognitive, a dedicated team has worked on this report, we have disclosed one of the team member involved in the publication and client consultation process for your reference. You can initiate the discussion her via Book an appointment
At cognitive, our research analyst works closely with Electric Hand Dryer market experts to validate the gathered data and have the expert's opinion available for our clients. You can book a consultation call with our research analyst and industry experts on board (Subject to time availability and paid consultation services)
The base year for the analysis is 2025. Historical data has been considered for the period from 2022 to 2025. The year 2026 is considered as the estimated base for forecasting, with projections covering the period from 2026 to 2034. When we deliver the report that time we updated report data till the purchase date.
From the database of Cognitive, this is an unique identification number of reports and it will also have different reports associated with it.
Report edition's total number of pages for pdf format (Approximate)
Rating and review received by the reader or subscriber of the said report.
Athenaeum Visualization Dashboard: Access your purchased data/Report/Service through a sophisticated, interactive interface. The Athenaeum Dashboard allows you to preview data/reports and store them in a customizable dashboard, enabling you to filter metrics and uncover deeper trends specific to your enterprise needs.
PDF Access: To ensure the highest level of data integrity and confidentiality, your premium report editions are delivered as password-protected PDF files. These are securely shared via email and remain accessible within your dedicated Athenaeum account for future reference.
Versatile Multi-Format Export (Excel & MS Word): We provide the flexibility to integrate our research directly into your internal workflows. Upon request, relevant quantitative data and qualitative insights from your purchased reports can be provided in fully editable Microsoft Excel and Word formats.
Multiple Cloud Accounts: Benefit from a dedicated, encrypted cloud account that ensures your market intelligence is available on-demand. Access your research from any device, at any time, and from any location. Multiple Accounts facilitating seamless collaboration across your collegue or whole organization.
Athenaeum AI Assistant(Value-Added Service): Elevate your research capabilities with Athenaeum AI Assistant, our proprietary 24/7 research assistant. Equivalent in depth to a dedicated research analyst, this AI-driven tool provides round-the-clock data support and instant insights to help you navigate complex market landscapes in real-time.
As Cognitive a market research and consulting firm, we can provide Electric Hand Dryer market Analysis and consultation services with the help of our data collection processes and Proprietary research methodology called Full Truth. We have in-house team of research analysts and network of industry experts on board. In fact, we provided high-impact consualtion services to the listed client in competitior analysis. As an extension of our bespoke consulting engagements, we also provide access to Proprietary datasets of market analysis publish, making authoritative industry intelligence accessible to the public domain.
Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence. along with Report Access and Athenaeum Dashboard Subscription — Revenue, Volume, Production, Trade Analysis, value chain and supply chain analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022-2025 | Base Year: 2025 | Forecast Period: 2026-2034 |
|---|---|
| Type Outlook: Segment Analysis | Inactivated/Killed Vaccines, Live-attenuated Vaccines, Recombinant Vaccines |
| Route of Administration Outlook: Segment Analysis | Intramuscular, Intranasal, Subcutaneous |
| Indication Outlook: Segment Analysis | Influenza, Measles, Mumps & Rubella, Coronavirus Disease (COVID-19), Others |
|---|---|
| Age Group Outlook: Segment Analysis | Pediatric, Adults |
| End User Outlook: Segment Analysis | Physician’s Office, Hospitals, Clinics, Pharmacies/Stores |
| Regions & Countries Analysis |
|
Share your contact details to receive free updated sample copy/pages of the recently published edition of Electric Hand Dryer Market Report 2025.
According to Cognitive Market Research, the global Respiratory virus vaccines market size will be USD 93824.8 million in 2025. It will expand at a compound annual growth rate (CAGR) of 3.00% from 2025 to 2033.
Market Drivers:
|
Market Restrains:
|
Market Trends:
|
| Market Size | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| Global Electric Hand Dryer Market Sales Revenue | xxxx | $ 1524.5 Million | $ 2821.7 Million | 8% |
| North America Electric Hand Dryer Market Sales Revenue | xxxx | $ 564.07 Million | $ 931.2 Million | 6.5% |
| United States Electric Hand Dryer Market Sales Revenue | xxxx | $ 445.05 Million | xxxx | 6.3% |
| Canada Electric Hand Dryer Market Sales Revenue | xxxx | $ 67.69 Million | xxxx | 7.3% |
| Mexico Electric Hand Dryer Market Sales Revenue | xxxx | $ 51.33 Million | xxxx | 7% |
| Europe Electric Hand Dryer Market Sales Revenue | xxxx | $ 442.1 Million | $ 761.9 Million | 7% |
| United Kingdom Electric Hand Dryer Market Sales Revenue | xxxx | $ 74.27 Million | xxxx | 7.8% |
| France Electric Hand Dryer Market Sales Revenue | xxxx | $ 40.67 Million | xxxx | 6.2% |
| Germany Electric Hand Dryer Market Sales Revenue | xxxx | $ 87.54 Million | xxxx | 7.2% |
| Italy Electric Hand Dryer Market Sales Revenue | xxxx | $ 38.02 Million | xxxx | 6.4% |
| Russia Electric Hand Dryer Market Sales Revenue | xxxx | $ 68.53 Million | xxxx | 6% |
| Spain Electric Hand Dryer Market Sales Revenue | xxxx | $ 36.25 Million | xxxx | 6.1% |
| Sweden Electric Hand Dryer Market Sales Revenue | xxxx | $ 13.71 Million | xxxx | 7.1% |
| Denmark Electric Hand Dryer Market Sales Revenue | xxxx | $ 9.28 Million | xxxx | 6.8% |
| Switzerland Electric Hand Dryer Market Sales Revenue | xxxx | $ 6.63 Million | xxxx | 6.7% |
| Luxembourg Electric Hand Dryer Market Sales Revenue | xxxx | $ 5.31 Million | xxxx | 7.3% |
| Rest of Europe Electric Hand Dryer Market Sales Revenue | xxxx | $ 61.89 Million | xxxx | 5.7% |
| Asia Pacific Electric Hand Dryer Market Sales Revenue | xxxx | $ 365.8 Million | $ 828.2 Million | 10.8% |
| China Electric Hand Dryer Market Sales Revenue | xxxx | $ 153.67 Million | xxxx | 10.3% |
| Japan Electric Hand Dryer Market Sales Revenue | xxxx | $ 50.49 Million | xxxx | 9.3% |
| South Korea Electric Hand Dryer Market Sales Revenue | xxxx | $ 43.91 Million | xxxx | 9.9% |
| India Electric Hand Dryer Market Sales Revenue | xxxx | $ 36.59 Million | xxxx | 12.7% |
| Australia Electric Hand Dryer Market Sales Revenue | xxxx | $ 19.03 Million | xxxx | 10.1% |
| Singapore Electric Hand Dryer Market Sales Revenue | xxxx | $ 7.32 Million | xxxx | 11.1% |
| Taiwan Electric Hand Dryer Market Sales Revenue | xxxx | $ 14.27 Million | xxxx | 10.6% |
| South East Asia Electric Hand Dryer Market Sales Revenue | xxxx | $ 24.15 Million | xxxx | 11.6% |
| Rest of APAC Electric Hand Dryer Market Sales Revenue | xxxx | $ 16.46 Million | xxxx | 10.6% |
| South America Electric Hand Dryer Market Sales Revenue | xxxx | $ 57.93 Million | $ 112.9 Million | 8.7% |
| Brazil Electric Hand Dryer Market Sales Revenue | xxxx | $ 24.79 Million | xxxx | 9.3% |
| Argentina Electric Hand Dryer Market Sales Revenue | xxxx | $ 9.73 Million | xxxx | 9.6% |
| Colombia Electric Hand Dryer Market Sales Revenue | xxxx | $ 5.16 Million | xxxx | 8.5% |
| Peru Electric Hand Dryer Market Sales Revenue | xxxx | $ 4.75 Million | xxxx | 8.9% |
| Chile Electric Hand Dryer Market Sales Revenue | xxxx | $ 4.17 Million | xxxx | 9% |
| Rest of South America Electric Hand Dryer Market Sales Revenue | xxxx | $ 9.33 Million | xxxx | 7.8% |
| Middle East Electric Hand Dryer Market Sales Revenue | xxxx | $ 60.98 Million | $ 124.2 Million | 9.3% |
| Qatar Electric Hand Dryer Market Sales Revenue | xxxx | $ 4.88 Million | xxxx | 8.8% |
| Saudi Arabia Electric Hand Dryer Market Sales Revenue | xxxx | $ 21.46 Million | xxxx | 9.6% |
| Turkey Electric Hand Dryer Market Sales Revenue | xxxx | $ 4.88 Million | xxxx | 9.9% |
| UAE Electric Hand Dryer Market Sales Revenue | xxxx | $ 12.56 Million | xxxx | 9.8% |
| Egypt Electric Hand Dryer Market Sales Revenue | xxxx | $ 3.66 Million | xxxx | 9.1% |
| Rest of Middle East Electric Hand Dryer Market Sales Revenue | xxxx | $ 13.54 Million | xxxx | 8.5% |
| Africa Electric Hand Dryer Market Sales Revenue | xxxx | $ 33.54 Million | $ 63.5 Million | 8.3% |
| Nigeria Electric Hand Dryer Market Sales Revenue | xxxx | $ 2.68 Million | xxxx | 8.5% |
| South Africa Electric Hand Dryer Market Sales Revenue | xxxx | $ 11.81 Million | xxxx | 9.2% |
Electric Hand Dryer Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
A respiratory disease vaccine is a type of immunization designed to protect against infections caused by pathogens that typically affect the respiratory system. These vaccinations reduce the likelihood of developing respiratory disorders by training the immune system to recognise and defend against specific respiratory invaders, such as bacteria or viruses. They act as a preventative strategy, reducing the severity, consequences, and spread of respiratory infections. The increasing global burden of respiratory illnesses is driving the respiratory virus vaccine market. An aging population and rising air pollution levels all contribute to an increase in the incidence of respiratory diseases such as influenza, respiratory syncytial virus, pneumonia, and COVID-19. Due to the risk of infection and complications from respiratory diseases, it is critical to prevent their spread as soon as possible
In August 2022, GSK PLC, a UK-based biopharma company, paid an undisclosed sum for Affinivax Inc. GSK Plc. will use this acquisition to strengthen its commitment to drug and vaccine innovation, including the development of a next-generation 24-valent pneumococcal vaccine candidate (AFX3772). Affinivax Inc. is a clinical-stage biotechnology company headquartered in the United States that focuses on developing vaccines and immunotherapies for a variety of diseases, including respiratory diseases. https://www.gsk.com/en-gb/media/press-releases/gsk-completes-acquisition-of-affinivax-inc/
The rising incidence of tuberculosis is expected to drive future growth in the respiratory virus vaccines market. Tuberculosis (TB) is a respiratory disease caused by the bacterium Mycobacterium tuberculosis. It primarily affects the lungs but can also affect other organs and systems in the body, leading to a variety of complications. The rising incidence of tuberculosis can spur efforts to develop and distribute respiratory disease vaccines to combat tuberculosis. For instance, in November 2023, the Centers for Disease Control and Prevention, a US-based government agency, reported 8,331 tuberculosis (TB) cases in the United States, a 5.9% increase over 2021. The incidence rate increased to 2.5 cases per 100,000 people, up 5.5% from the previous year. As a result, the rising incidence of tuberculosis will drive demand for respiratory disease vaccines
The rising smoking rate is expected to drive future growth in the respiratory virus vaccine market. Smoking is the act of inhaling and exhaling smoke produced by burning tobacco or tobacco-containing products, which can lead to a variety of health problems, such as tracheitis, heart disease, stroke, and cancer. Individuals who smoke may benefit from respiratory disease vaccines, which offer some protection against specific infections. For instance, according to Statistics Canada, a Canadian government agency, cigarette production increased by 5.8% in July 2022 over June 2021. Furthermore, the total number of cigarettes sold increased 1.3% from May 2022 to 1.4 billion in June 2022. As a result, the rising prevalence of smoking is driving the expansion of the respiratory virus vaccine market
Logistics and cold chain issues severely limit market growth in the respiratory virus vaccines market. Vaccines have stringent temperature requirements to maintain their effectiveness, necessitating a consistent cold chain system from production to distribution. Maintaining these temperatures may be difficult in areas with poor infrastructure, such as a scarcity of refrigeration units or unreliable transportation. This can lead to vaccine waste, decreased availability, and, ultimately, reduced immunisation rates. Furthermore, the logistical complexity of vaccine management for large-scale vaccination campaigns places a strain on resources, particularly in remote regions. As a result, logistical and cold chain issues impede the effective distribution of respiratory virus vaccines, reducing their accessibility and usefulness in preventing outbreaks.
The key trend in the respiratory syncytial virus (RSV) vaccine market is a growing emphasis on advancements in vaccine technology, particularly recombinant protein-based technology, to maintain their market position. Recombinant protein technology involves genetically engineering proteins to create vaccines that elicit an immune response. For instance, in May 2023, GlaxoSmithKline plc, a pharmaceutical company based in the United Kingdom, received FDA approval for Arexvy, the first respiratory syncytial virus (RSV) vaccine. This vaccine is specifically designed to prevent RSV-induced lower respiratory tract disease in people over the age of 60. Arexvy uses advanced recombinant protein-based technology to target the RSV fusion (F) protein, which is critical for the virus's ability to infect human cells
We have various report editions of Electric Hand Dryer Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
In 2025, sweeping US tariffs, called the Liberation Day Tariffs,have thrown the global consumer goods industry into turmoil. This has triggered retaliatory measures from trade partners, causing production costs to rise by 15-30% and creating severe supply chain disruptions.
The industry's deep reliance on China makes these tariffs especially damaging, with smaller brands being the most vulnerable. In response, successful companies are relying on market research to navigate the risks, diversifying their sourcing to countries like Vietnam, India, and Mexico, and using technology and product redesign to adapt and survive in this new protectionist trade environment.
The Respiratory virus vaccines market is highly competitive, characterised by the presence of several global and regional players offering a wide range of products. Key companies in the market, such as Johnson & Johnson Services, Inc., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., And SINOVAC., dominate through their extensive product portfolios, strong distribution networks and focus on innovation.
In May 2024, Sanofi and Novavax signed a co-exclusive licensing agreement to commercialise Novavax's adjuvanted COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines. This strategic partnership could broaden Sanofi's vaccine portfolio, strengthen its position in the post-pandemic vaccine market, and increase long-term vaccine sales. https://www.sanofi.com/en/media-room/press-releases/2024/2024-05-10-06-00-00-2879379 In October 2023, Modern, Inc. announced a significant milestone in the phase III study of their combination vaccine candidate, mRNA-1083, which targets both influenza and COVID-19 in the United States. This is a strategic move for Moderna, as mRNA-1083 is their first respiratory combination vaccine candidate to enter a phase III trial. This strategic approach may position Moderna as a pioneer in the development of novel respiratory disease vaccines. https://www.clinicaltrialsarena.com/analyst-comment/moderna-positive-phase-iii-data-covid-19-influenza-mrna-vaccine/
Top Companies Market Share in Electric Hand Dryer Industry: (In no particular order of Rank)
| Companies | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| GSK plc. | xxxx | xxxx | xxxx | xxxx |
| Johnson & Johnson Services Inc. | xxxx | xxxx | xxxx | xxxx |
| Pfizer Inc. | xxxx | xxxx | xxxx | xxxx |
| Sanofi | xxxx | xxxx | xxxx | xxxx |
| Serum Institute of India Pvt. Ltd. | xxxx | xxxx | xxxx | xxxx |
| SINOVAC | xxxx | xxxx | xxxx | xxxx |
| Bavarian Nordic | xxxx | xxxx | xxxx | xxxx |
| Merck & Co. | xxxx | xxxx | xxxx | xxxx |
| Inc. | xxxx | xxxx | xxxx | xxxx |
| AstraZeneca | xxxx | xxxx | xxxx | xxxx |
| EMERGENT | xxxx | xxxx | xxxx | xxxx |
| Novavax | xxxx | xxxx | xxxx | xxxx |
| INOVIO Pharmaceuticals | xxxx | xxxx | xxxx | xxxx |
| Moderna Inc. | xxxx | xxxx | xxxx | xxxx |
*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)
Request Any Company Profile for Preview Purpose OR Data Validation!
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Market Research, North America dominates the respiratory disease vaccine market due to the medical industry's complete maturation, heavy investments in research, favourable government policies and initiatives, rapid development in the field of vaccination, increased public awareness of the benefits of vaccines, and the presence of hundreds of establishments working to develop newer and more advanced vaccines
Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). This can be attributed to the region's efficient research laboratories. Additionally, there is a large population of people suffering from respiratory diseases in the region, and a large number of companies are working to develop a vaccine for diseases like COVID-19.
The current report Scope analyzes Electric Hand Dryer Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
According to Cognitive Market Research, the global Respiratory virus vaccines market size was estimated at USD 43521.6 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 34715.18 million in 2025 and will grow at a compound annual growth rate (CAGR) of 1.5% from 2025 to 2033.
According to Cognitive Market Research, the US had a major share in the Respiratory virus vaccines market with a market size of USD 27390.27 million in 2025 and is projected to grow at a CAGR of 1.3% during the forecast period. The U.S. Market's rising awareness of vaccination
The Canadian Respiratory virus vaccines market had a market share of USD 4165.82 million in 2025 and is projected to grow at a CAGR of 2.3% during the forecast period. Canada’s growing geriatric population.
The Mexico Respiratory virus vaccines market is projected to witness growth at a CAGR of 2.0% during the forecast period, with a market size of USD 3159.08 million in 2025..
According to Cognitive Market Research, the global Respiratory virus vaccines market size was estimated at USD 93824.8 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 27209.19 million in 2025 and will grow at a compound annual growth rate (CAGR) of 2.1% from 2025 to 2033.
The United Kingdom Respiratory virus vaccines market had a market share of USD 4571.14 million in 2025 and is projected to grow at a CAGR of 2.9% during the forecast period. In the UK, Respiratory virus vaccines sales witnessed an upswing due to strong emphasis on research and development
The France Respiratory virus vaccines market is projected to witness growth at a CAGR of 1.3% during the forecast period, with a market size of USD 2503.25 million in 2025.
According to Cognitive Market Research, the German Respiratory virus vaccines market size was valued at USD 5387.42 million in 2025 and is projected to grow at a CAGR of 2.3% during the forecast period. In Germany, advanced healthcare systems
The Italy Respiratory virus vaccines market is projected to witness growth at a CAGR of 1.5% during the forecast period, with a market size of USD 2339.99 million in 2025.
The Russia Respiratory virus vaccines market is projected to witness growth at a CAGR of 1.1% during the forecast period, with a market size of USD 4217.42 million in 2025
The Spain Respiratory virus vaccines market is projected to witness growth at a CAGR of 1.2% during the forecast period with a market size of USD 2231.15 million in 2025
The Sweden Respiratory virus vaccines market is projected to witness growth at a CAGR of 2.2% during the forecast period, with a market size of USD 843.48 million in 2025.
The Denmark Respiratory virus vaccines market is projected to witness growth at a CAGR of 1.9% during the forecast period, with a market size of USD 571.39 million in 2025
The Switzerland Respiratory virus vaccines market is projected to witness growth at a CAGR of 1.7% during the forecast period, with a market size of USD 408.14 million in 2025.
The Luxembourg Respiratory virus vaccines market is projected to witness growth at a CAGR of 2.4% during the forecast period, with a market size of USD 326.51 million in 2025.
The Rest of Europe's Respiratory virus vaccines market is projected to witness growth at a CAGR of 0.8% during the forecast period, with a market size of USD 3809.29 million in 2025.
According to Cognitive Market Research, the global Respiratory virus vaccines market size was estimated at USD 93824.8 Million, out of which APAC held the market share of around 23% of the global revenue with a market size of USD 22517.95 million in 2025 and will grow at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2033.
According to Cognitive Market Research, the China Respiratory virus vaccines market size was valued at USD 9457.54 million in 2025 and is projected to grow at a CAGR of 5.1% during the forecast period. Respiratory virus vaccines surged in China due to growing government initiatives
The Japan Respiratory virus vaccines market is projected to witness growth at a CAGR of 4.1% during the forecast period, with a market size of USD 3107.48 million in 2025
The South Korea Respiratory virus vaccines market had a market share of USD 2702.15 million in 2025 and is projected to grow at a CAGR of 4.7% during the forecast period. India's increasing burden of respiratory diseases
The Indian Respiratory virus vaccines market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 2251.80 million in 2025.
The Australian Respiratory virus vaccines market is projected to witness growth at a CAGR of 4.9% during the forecast period, with a market size of USD 1170.93 million in 2025.
The Singapore Respiratory virus vaccines market is projected to witness growth at a CAGR of 5.9% during the forecast period, with a market size of USD 450.36 million in 2025.
The Taiwan Respiratory virus vaccines market is projected to witness growth at a CAGR of 5.4% during the forecast period, with a market size of USD 878.20 million in 2025.
The South East Asia Respiratory virus vaccines market is projected to witness growth at a CAGR of 6.4% during the forecast period, with a market size of USD 1486.18 million in 2025.
The Rest of APAC Respiratory virus vaccines market is projected to witness growth at a CAGR of 5.4% during the forecast period, with a market size of USD 1013.31 million in 2025.
According to Cognitive Market Research, the global Respiratory virus vaccines market size was estimated at USD 93824.8 Million, out of which South America held the market share of around 5% of the global revenue with a market size of USD 3565.34 million in 2025 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2025 to 2033.
According to Cognitive Market Research, the Brazil Respiratory virus vaccines market size was valued at USD 1525.97 million in 2025 and is projected to grow at a CAGR of 4.3% during the forecast period. Respiratory virus vaccines flourished in Brazil due to increasing number of respiratory virus cases.
Argentina's Respiratory virus vaccines market had a market share of USD 598.98 million in 2025 and is projected to grow at a CAGR of 4.6% during the forecast period. Argentina's rising healthcare awareness.
Colombia Respiratory virus vaccines market is projected to witness growth at a CAGR of 3.5% during the forecast period, with a market size of USD 317.32 million in 2025
Peru Respiratory virus vaccines market is projected to witness growth at a CAGR of 3.9% during the forecast period, with a market size of USD 292.36 million in 2025.
Chile Respiratory virus vaccines market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 256.70 million in 2025
The Rest of South America's Respiratory virus vaccines market is projected to witness growth at a CAGR of 2.8% during the forecast period, with a market size of USD 574.02 million in 2025.
According to Cognitive Market Research, the global Respiratory virus vaccines market size was estimated at USD 93824.8 Million, out of which the Middle East held the major market share of around 2% of the global revenue with a market size of USD 3752.99 million in 2025 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2025 to 2033..
The Qatar Respiratory virus vaccines market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 300.24 million in 2025. Respiratory virus vaccines sales flourish due to the higher public awareness about health and the value of immunizations
The Saudi Arabia Respiratory virus vaccines market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 1321.05 million in 2025.
The Turkey Respiratory virus vaccines market is projected to witness growth at a CAGR of 4.8% during the forecast period, with a market size of USD 300.24 million in 2025. Respiratory virus vaccines sales flourished in Turkey due to increasing population and urbanization
The UAE Respiratory virus vaccines market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 773.12 million in 2025.
The Egypt Respiratory virus vaccines market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 225.18 million in 2025.
The Rest of the Middle East Respiratory virus vaccines market is projected to witness growth at a CAGR of 3.4% during the forecast period, with a market size of USD 833.16 million in 2025
According to Cognitive Market Research, the global Respiratory virus vaccines market size was estimated at USD 93824.8 Million, out of which the Africa held the major market share of around 2% of the global revenue with a market size of USD 2064.15 million in 2025 and will grow at a compound annual growth rate (CAGR) of 3.3% from 2025 to 2033..
The Nigeria Respiratory virus vaccines market is projected to witness growth at a CAGR of 3.5% during the forecast period, with a market size of USD 165.13 million in 2025. Respiratory virus vaccines sales flourish due to the rising awareness of vaccination importance.
The South Africa Respiratory virus vaccines market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 726.58 million in 2025.
The Rest of Africa Respiratory virus vaccines market is projected to witness growth at a CAGR of 2.5% during the forecast period, with a market size of USD 1172.43 million in 2025.
Conclusion
Senior Research Associate at Cognitive Market Research
LinkedIn | Profile | Book Appointment
Anushka Gore is a dedicated market research professional specializing in the consumer goods industry. At Cognitive Market Research, she focuses on analyzing evolving consumer preferences, product innovation, and brand strategies across global markets.
Her expertise spans personal care, household products, apparel, and lifestyle goods, providing actionable insights that help brands understand shifting demands patterns and market opportunities. With a keen eye for consumer behavior and emerging trends, Anushka delivers research-driven intelligence that supports strategic decision-making and sustainable business growth in the competitive consumer goods landscape.
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations.
In her current role, Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses. Her collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization.Anushka remains an invaluable asset in the dynamic landscape of market research.
Global Electric Hand Dryer Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Electric Hand Dryer Industry growth. Electric Hand Dryer market has been segmented with the help of its Type Outlook:, Route of Administration Outlook: Indication Outlook:, and others. Electric Hand Dryer market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
How are Segments Performing in the Global Respiratory Virus Vaccines Market?
According to Cognitive Market Research, inactivated or killed vaccines hold the majority of the respiratory virus vaccine market. This is mainly due to their long history of use and safety records. Inactivated vaccines, such as those for influenza, have been popular with the general public and have been the primary focus of vaccination campaigns in most parts of the world
The most rapidly expanding category is recombinant vaccines. Biotechnology advances have fueled growth by allowing for the production of more potent vaccines with fewer adverse effects. Recombinant vaccines can target specific viral proteins, resulting in stronger immune responses. The growing emphasis on personalised medicines, as well as the need for an immediate response to new respiratory viruses, are also driving market growth for recombinant vaccines
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Electric Hand Dryer Industry. Request a Free Sample PDF!
According to Cognitive Market Research, the intramuscular segment dominates the market for respiratory virus vaccines. This is primarily due to the fact that intramuscular injections are the most common method of vaccine delivery, including influenza and COVID-19 vaccines. The method is well-proven, established, and popular, with a strong immune response
The fastest growing segment is intranasal delivery. The convenience and ease of administration are driving the growth, particularly among populations that are resistant to needles, such as children. Intranasal vaccines can also induce mucosal immunity, which is particularly useful against respiratory viruses. With continued research and development, the intranasal segment will expand rapidly in the coming years.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
According to Cognitive Market Research, in 2025, the COVID-19 segment had the largest market share in the respiratory virus vaccine market. With growing concerns about the spread of SARS-CoV-2 infection, the global scientific community has quickly developed and approved several COVID-19 vaccines. These were approved in order to prevent the occurrence and spread of the virus. Pfizer-BioNTech and Moderna developed an mRNA-based vaccine, while AstraZeneca and Johnson & Johnson developed a viral vector vaccine, and SINOVAC and Bharat Biotech developed an inactivated one. These vaccines were used to immunise the vast majority of the population during the pandemic, propelling the segment's overall growth.
Influenza is the most rapidly expanding segment in the respiratory virus vaccines market. The rising incidence of influenza outbreaks, along with increased awareness of the need for vaccination, particularly during flu seasons, is fueling growth. New and improved influenza vaccines, such as those targeting multiple strains, are also fueling the growth of this segment.
According to Cognitive Market Research, in the respiratory disease vaccine market, the adult segment accounted for the largest market share in 2025. The increasing prevalence of respiratory diseases among the adult population is driving the segment's growth. The global population is aging, and a greater proportion of older adults are at higher risk of respiratory infections and complications. This has resulted in a greater emphasis on immunization efforts aimed at this age group, including the development and promotion of vaccines designed specifically for adults. Furthermore, growing awareness among adults about the importance of vaccination is expected to drive segment growth
The pediatric segment is expected to grow at the fastest rate over the forecast period. The segment's growth is attributed to the widespread vaccinations given to infants and newborns to combat various respiratory diseases. For instance, the MMR vaccine, which protects against measles, mumps, and rubella, is typically administered twice: once at 12-15 months of age and again at 4-6 years of age. Furthermore, increased awareness, expanded immunization schedules, technological advancements, government initiatives, the burden of respiratory diseases, and the impact of the COVID-19 pandemic all contribute to the growth of respiratory vaccines for pediatrics. The market is expected to grow further as prevention and vaccination efforts for pediatric respiratory infections continue
According to Cognitive Market Research, the hospital segment accounted for the largest share of the respiratory disease vaccine market in 2025, which can be attributed to the increasing prevalence of respiratory diseases in the population. Hospitals employ dedicated healthcare professionals, such as nurses and doctors, who are trained to administer vaccinations, including respiratory vaccines. They provide vaccination services to hospitalized patients, particularly those who are more vulnerable to respiratory diseases, such as the elderly or people with underlying health conditions. Furthermore, retail pharmacies frequently offer walk-in vaccination services, which allow people to get respiratory vaccines without an appointment. This flexibility allows for the management of busy schedules as well as the promotion of vaccine uptake in the general population.
Clinics are the most rapidly expanding segment of the respiratory virus vaccines market. Clinics, especially urgent care and community health clinics, are becoming more and more primary sites for vaccination because they are accessible and convenient for patients. The increase in vaccination campaigns and public health programs designed to boost immunization rates has resulted in more emphasis on clinics as vaccination locations.
Disclaimer:
| Type Outlook: | Inactivated/Killed Vaccines, Live-attenuated Vaccines, Recombinant Vaccines |
| Route of Administration Outlook: | Intramuscular, Intranasal, Subcutaneous |
| Indication Outlook: | Influenza, Measles, Mumps & Rubella, Coronavirus Disease (COVID-19), Others |
| Age Group Outlook: | Pediatric, Adults |
| End User Outlook: | Physician’s Office, Hospitals, Clinics, Pharmacies/Stores |
| List of Competitors | GSK plc., Johnson & Johnson Services Inc., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., SINOVAC, Bavarian Nordic, Merck & Co., Inc., AstraZeneca, EMERGENT, Novavax, INOVIO Pharmaceuticals, Moderna Inc. |
Chapter 1 2026 Geopolitical Outlook - Electric Hand Dryer Market Detailed Analysis
This chapter isn't just about technology; it’s about certainty. We show you how AI is being used in leading industries so you can apply those same 'High-Speed' and 'High-Accuracy' principles to your own market strategy
Chapter 2 AI's Impact on Market - Detailed Qualitative Analysis
This chapter will help you gain GLOBAL Market Analysis of Electric Hand Dryer. Further deep in this chapter, you will be able to review Global Electric Hand Dryer Market Split by various segments and Geographical Split.
Chapter 3 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Electric Hand Dryer. Further deep in this chapter, you will be able to review North America Electric Hand Dryer Market Split by various segments and Country Split.
Chapter 4 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Electric Hand Dryer. Further deep in this chapter, you will be able to review Europe Electric Hand Dryer Market Split by various segments and Country Split.
Chapter 5 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Electric Hand Dryer. Further deep in this chapter, you will be able to review Asia Pacific Electric Hand Dryer Market Split by various segments and Country Split.
Chapter 6 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Electric Hand Dryer. Further deep in this chapter, you will be able to review South America Electric Hand Dryer Market Split by various segments and Country Split.
Chapter 7 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Electric Hand Dryer. Further deep in this chapter, you will be able to review Middle East Electric Hand Dryer Market Split by various segments and Country Split.
Chapter 8 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Electric Hand Dryer. Further deep in this chapter, you will be able to review Middle East Electric Hand Dryer Market Split by various segments and Country Split.
Chapter 9 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Electric Hand Dryer. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 10 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 11 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Outlook: Analysis 2019 -2031, will provide market size split by Type Outlook:. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Type Outlook: Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Route of Administration Outlook: Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 14 Market Split by Indication Outlook: Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 15 Market Split by Age Group Outlook: Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 16 Market Split by End User Outlook: Analysis 2022 - 2034
Chapter 17 Electric Hand Dryer Price Trend Analysis
Chapter 18 Electric Hand Dryer Import/Export Analysis
Chapter 19 Electric Hand Dryer Production Analysis
Chapter 20 Gap Analysis
Chapter 21 Strategy Analysis
Chapter 22 Profitability and Gross Margin Analysis
Chapter 23 TAM Analysis
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Electric Hand Dryer market
Chapter 24 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 25 Research Methodology and Sources
1 Data Gathering
2 Data Validation
3 Data Presentation
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for our full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants your team direct access to our lead analysts for bespoke strategic consultation.